NDAINJECTIONINJECTABLEPriority Review
Approved
May 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
CARBOCAINE (mepivacaine hydrochloride) by Pfizer is clinical pharmacology mepivacaine hydrochloride is a potent local anesthetic whose effectiveness and safety have been well established in human medicine and dentistry. First approved in 1960.
Drug data last refreshed 15h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Carbocaine (mepivacaine hydrochloride) is a potent local anesthetic administered by injection with 2–2.5× the effectiveness of procaine and comparable to lidocaine. It produces rapid, marked local anesthesia lasting several hours, enabling prolonged surgical procedures without delay. Originally developed for veterinary medicine, it demonstrates excellent tissue compatibility and can be enhanced with epinephrine for extended effect.
LOE Approaching
As a product approaching loss of exclusivity with moderate competitive pressure (30/100), the brand team is likely consolidating market position and optimizing margins rather than pursuing growth.
Mechanism of Action
CLINICAL PHARMACOLOGY Mepivacaine hydrochloride is a potent local anesthetic whose effectiveness and safety have been well established in human medicine and dentistry. Laboratory and clinical studies in animals have confirmed its value in veterinary medicine. Its anesthetic activity is two to two…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Carbocaine offers limited career growth trajectory as the product approaches or resides in the LOE phase; roles focus on defending market share, cost optimization, and compliance rather than innovation or expansion. This assignment is best suited for professionals seeking stability and operational expertise rather than launch-stage or growth-stage challenges.
Worked on CARBOCAINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.